Royalty Pharma Raises $2.2B In Year's Largest IPO
Biopharmaceutical royalties company Royalty Pharma debuted strongly in public markets Tuesday after raising nearly $2.2 billion, completing the year's largest initial public offering with the help of three law firms....To view the full article, register now.
Already a subscriber? Click here to view full article